Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Payables (2016 - 2025)

Harte Hanks has reported Payables over the past 16 years, most recently at $13.1 million for Q4 2025.

  • Quarterly Payables fell 2.48% to $13.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Dec 2025, down 2.48% year-over-year, with the annual reading at $13.1 million for FY2025, 2.48% down from the prior year.
  • Payables was $13.1 million for Q4 2025 at Harte Hanks, down from $18.1 million in the prior quarter.
  • Over five years, Payables peaked at $23.2 million in Q4 2023 and troughed at $13.1 million in Q4 2025.
  • The 5-year median for Payables is $18.3 million (2023), against an average of $18.4 million.
  • Year-over-year, Payables surged 39.26% in 2022 and then tumbled 42.06% in 2024.
  • A 5-year view of Payables shows it stood at $16.1 million in 2021, then skyrocketed by 39.26% to $22.5 million in 2022, then grew by 3.16% to $23.2 million in 2023, then plummeted by 42.06% to $13.4 million in 2024, then dropped by 2.48% to $13.1 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Payables are $13.1 million (Q4 2025), $18.1 million (Q3 2025), and $18.6 million (Q2 2025).